Pfizer’s Friendly Tack: McKinnell Shares Credit With Hassan, Offers No. 2 Spot

Pfizer's $60 bil. offer for Pharmacia could be a landmark event in the remaking of the Pfizer image, as well as a large-scale strategic move to broaden Pfizer's product line into new specialties and deepen the pipeline